Endoscopy 2025; 57(02): 107-115
DOI: 10.1055/a-2408-6905
Original article

Endoscopic ultrasonography-guided coil embolization and cyanoacrylate injection versus cyanoacrylate injection alone for gastric varices: a randomized comparative study

Autoren

  • Ashok Jhajharia

    1   Gastroenterology, Sawai Man Singh Medical College and Hospital, Jaipur, India (Ringgold ID: RIN29785)
  • Sumit Yadav

    1   Gastroenterology, Sawai Man Singh Medical College and Hospital, Jaipur, India (Ringgold ID: RIN29785)
  • Shashank Singh

    1   Gastroenterology, Sawai Man Singh Medical College and Hospital, Jaipur, India (Ringgold ID: RIN29785)
  • Prachis Ashdhir

    1   Gastroenterology, Sawai Man Singh Medical College and Hospital, Jaipur, India (Ringgold ID: RIN29785)
  • Sandeep Nijhawan

    1   Gastroenterology, Sawai Man Singh Medical College and Hospital, Jaipur, India (Ringgold ID: RIN29785)
Clinical Trial: Registration number (trial ID): CTRI/2022/08/045100, Trial registry: Clinical Trials Registry India (http://www.ctri.nic.in/Clinicaltrials), Type of Study: Randomized


Graphical Abstract

Abstract

Background Bleeding from gastric varices is life-threatening, with significant rebleeding risk despite standard cyanoacrylate glue injection therapy. Our aim was to evaluate the efficacy and safety of endoscopic ultrasonography (EUS)-guided coil embolization with cyanoacrylate injection (Coil+CYA) compared with EUS-guided cyanoacrylate injection alone (CYA) for the treatment of gastric varices.

Methods The study was conducted at a tertiary referral center in India, using a single-blinded, prospective, and parallel-group randomized design. A total of 50 patients were randomly assigned (1 : 1) to Coil+CYA or CYA. The primary outcome was clinical success (i.e. variceal obliteration). Secondary outcomes involved technical success, gastric variceal recurrence during follow-up, rebleeding episodes, reintervention, and survival.

Results Post-intervention, gastric variceal obliteration assessed by EUS was higher in the Coil+CYA group (100% vs. 92.3%; P = 0.49), with both groups achieving 100% technical success. Rebleeding episodes during 0–12 and 12–24 weeks were comparable in the two groups. At 12 weeks, on EUS, variceal reappearance was less common in the Coil+CYA group (12.5% vs. 19.2%; P = 0.70). Significantly fewer reinterventions were needed in the Coil+CYA group (20.8% vs. 53.8%; P = 0.03). The time to reintervention was significantly longer in the Coil+CYA group (P = 0.01), and the survival time was also longer (P = 0.04).

Conclusions EUS-guided coil embolization with cyanoacrylate injection achieved superior clinical success, reducing the need for reintervention and resulting in improved survival compared with cyanoacrylate injection alone.



Publikationsverlauf

Eingereicht: 29. Dezember 2023

Angenommen nach Revision: 18. Juli 2024

Artikel online veröffentlicht:
18. September 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany